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Considerations on the
Sulphonamides with a





Trials conducted with sulphones and sulphonamides
combined with a pyrimidine derivative for the assessment
of their value in the treatment of malaria are reported,
and reasons for the use of one of these combinations
- Maloprim - by the Malaria Service of Mozambique
are presented.
S. Afr. Med. J., 48, 1351 (1974).
In the chemotherapy of malaria, quinine has, as is known,
a place all of its own. For long the sole effective anti-
malarial in use, it still has today, under special circum-
stances, an appreciable use. Scarcity of quinine in world
markets forced research into substitutes and thus oradual-
Iy, several synthetic antimalarials were found and ;re now
widely used, their therapeutic efficiency only occasionally
being queried.
Recently, however, the discovery was made of resistance
to synthetic antimalarials of P. falciparum, at first to the
biguanides and diaminopyrimidines and, lately, to 4-
aminoquinotines, especially chloroquine. This situation is
evidently causing concern among clinicians and others
responsible for the preparation and execution of control
and eradication programmes. More particularly among
malariologists, forced to regard malaria as a public health
pr?blem, affecting extensive areas and millions of people,
thiS concern is added to their ever-present desire to find
an ideal antimalarial.
Research into new means to face this understandably
troublesome situation has resulted in a better knowledge
of the previously known antimalarial action of sulphones
and sulphonamides, especially when combined with a
pyrimidine derivative (pyrimethamine or trimethoprim) be-
cause of their synergic and potentialising action. The Mala-
ria Service of Mozambique has undertaken trials with the
drug association mentioned. It should be mentioned that
it has not been possible, for various reasons, to use the
recommended and demanding scientific precision in the
preparation, execution and analysis of these trials. Per-
formed by personnel unfamiliar with this type of work,
under rural conditions, they suffer naturally from deficien-
cies which, however, do not entirely rob them of value
and practical utility.
:vIalaria Service, Louren4;o Marques, Mozambique
A. BOTELHO
Paper presented at the Malaria Symposium held at Nelspruit, Eastern
Transvaal on 27 January 1973 under the auspices of the Lowveld Division
of ~he Northern Transvaal Branch of the Medical Association of South
AfrIca.
The first trial was done with the combination pyrimetha-
mIne·dapsone, Maloprim (12,5 mg pyrimethamine and
100 mg dapsone) provided by Burroughs Wellcome. It was
undertaken during the maximal transmission season in
186 immune individuals with P. falciparllm infec;ion.
living in scattered settlements in an area of mes-endemic
~alaria under 2 cycles of intradomiciliary DDT applica-
tlons. Maloprim was given as a single dose of one tablet
for adults and less for children.
The results were a notable schizonticidal action on
P. falciparllm; probably radical cure of infection since
no relapses were seen during a reasonable period of ob-
servation; and presumably a reasonably prolonoed pro-
phylaxis. '"
Other findings during this trial were: in the 186 cases.
22 showed sexual forms of the parasite at the first examina-
tion, of which 3 persisted for 48 hours; at the end of 48
hours gametocytes were seen in 13 individuals not showing
these forms previously; and no gametocytes were found
in later examinations. The behaviour of these sexual forms
of the parasite was, thus, ambiguous in the presence of
the drug.
MALOPRlM PLUS CAMOPRlM
A new trial was organised, utilising the as ociation of
Camoprim, 2 tablets, with an increased amount of Malo-
prim, 2 tablets per adult and corresponding lower doses
in children. This trial was undertaken in 242 cases in a
population of I 687 living in 10 localities of 2 areas nOl
included in the house-spraying operations.
Follow-up of these cases showed (excluding absentees)
the behaviour of gametocytes to be similar to that observed
with the administration of Maloprirn alone. The thera-
peutic action of a single tablet of Maloprirn is comparable
to that obtained with the combination of 2 tablets of
Camoprim (schizonticide and gametocide containing a
total of 300 mg amodiaquine and 30 mg primaquine) and
2 tablets of Maloprim.
I should add that with this dosage a few cases of
jaundice were observed, probably haemolytic. Attention is
drawn to this occurrence, inasmuch as there is, at times,
a tendency for the simultaneous or sequential administra-
tion of antimalarial drugs each exhibiting haemolytic pro-
perties, without due regard of these properties.
In a further trial in an area with a high parasite index
(70%), 229 cases with P. falciparum infection - of which
41 showed sexual forms of this parasite and 49 had
asexual forms of P. malariae - were treated with a single
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tablet of Maloprim and 2 tablets of Camoprim in adults
(and corresponding doses in children) with similar results.
SULPHONAMIDE AND PYRIMETHAMINE
Brief mention is now made of a trial with the combina-
tion of a long-acting sulphonamide and pyrimethamin~
Fanasil-pyrimethamine (500 mg Fanasil plus 25 mg pyri-
methamine) kindly provided by Hoffmann-La Roche. The
tablets were given in a single dose, 2 to 3 tablets in adults
and lower doses in children. The trial was undertaken in an
endemic area, with a prevalence of about 68 %, where no
antimalarial measures were in effect on 276 patients.
All had P. falciparum infections, of which 33 showed
sexual forms and 49 were also infected with P. malariae.
The results showed a notable schizonticidal effect
against P. falciparum; a marked gametocidal action
particularly during the 5th week, whence its special epi-
demiological interest; and a notable and rapid schizonti-
cidal action against P. malariae. with negative parasitaemia
up to the 5th week.
SULPHONAMIDE AND TRIMETHOPRIM
The Malaria Service of Mozambique has a trial under
way in which use is made of a combination of a delayed
action sulphonamide with tri..methoprim.
It is not yet possible to mention results, but observa-
tions can be made from the treatment of 4 acute cases
where I personally used this compound, administered in a
s:ngle dose of 6 tablets per adult. The patients were im-
mune. and clinical improvement was seen at the end of
24 - 48 hours.
In this trial, as in those mentioned before, the appear-
ance after treatment of gametocytes is obvious in indivi-
duals not showing them at the initial observation. This
apparent gametocytogenesis, initially intriguing, should
cause no worry, as has, indeed, been shown by others. It
is believed, on good grounds, that these are degenerating
forms and, due to the action of pyrimethamine, unviable;
thus, a problem would only be present in the case of
pyrimethamine-resistant itraim.
DISCUSSION
In view of the results registered in the various trials men-
tioned above and of those reported in the literature, the
Malaria Service of Mozambique has for some time, pre-
sumptively, been using, in preventive and radical treatment,
especially in mass treatment, the combination dapsone
plus pyrimethamine - Maloprim.
The Service is not unaware that in Africa so far no
P. falciparum strains resistant to the 4-aminoquinolines
have appeared (Technical Report, 1967; Richard Lenoble,
1971) and we have reached the same conclusion. We are
also aware of the recommendation that these new thera-
peutic weapons should be held in reserve against the
eventuality of the appearance of chloroquine-resistant
parasite strains.
We further know that mass administration of sulphones
and sulphonamides without the recommended and neces-
sary regularity - seldom possible under our conditions -
may lead to the appearance of resistant strains among
pathogenic micro-organisms responsible for endemic tro-
pical infections, although - I would stress - an asso-
ciation of drugs, each interfering at two different points
of the parasite's metabolic chain - as is the case in point
- should destroy this hypothesis of resistance.
Malaria is a prevalent endemic disease in Mozambique,
against which the responsible State Health Service is
waging, on a priority basis, an extensive and intensive
campaign. In this effort, chemotherapy has a prominent
place, and the drug has to be carefully chosen.
From our essentially practical point of view, the com-
bination of dapsone and pyrimethamine, widely used by
us, exhibits the following useful qualities: (a) economy of
mass prophylaxis and cure: low cost, single dose; (b) easy
and rapid administration: water-soluble, tasteless tablets;
(c) simultaneous schizonticidal, sporonticidal and game-
tocidal action of undoubted clinical and, more notably,
epidemiological usefulness; (d) good tolerance; (e) multi-
efficiency: a wide spectrum antibacterial action of great
advantage in the effort directed against some of the various
endemic diseases in Mozambique, in a co-ordinated large-
scale public health campaign evolving towards greater
validity and efficiency.
